Long human CHGA flanking chromosome 14 sequence required for optimal BAC transgenic "rescue" of disease phenotypes in the mouse Chga knockout

Physiological Genomics

Volumn 41, Issue 1, 2010, Pages 91-101

  Vaingankar, Sucheta M ^a   Li, Ying ^a   Corti, Angelo ^c   Biswas, Nilima ^a   Gayen, Jiaur ^a   O'Connor, Daniel T ^a,b   Mahata, Sushil K ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Bacterial artificial chromosome; Blood pressure; Catecholamine; Chromogranin A; Hypertension; Stress

Indexed keywords

CHROMOGRANIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; CATECHOLAMINE RELEASE; CHROMOSOME 14; DNA FLANKING REGION; ENVIRONMENTAL STRESS; GENE EXPRESSION; GENOME; HYPERTENSION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION;

ADRENAL GLANDS; ANIMALS; BASE SEQUENCE; BLOOD PRESSURE; CATECHOLAMINES; CHROMOGRANIN A; CHROMOSOMES, ARTIFICIAL, BACTERIAL; CHROMOSOMES, HUMAN, PAIR 14; GENE DOSAGE; GENE EXPRESSION REGULATION; HUMANS; MICE; MICE, KNOCKOUT; MUTAGENESIS, INSERTIONAL; PHENOTYPE; RESTRAINT, PHYSICAL; RNA, MESSENGER; STRESS, PHYSIOLOGICAL; TRANSGENES;

BACTERIA (MICROORGANISMS); MUS;

EID: 77949768138     PISSN: 10948341     EISSN: 15312267     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00086.2009     Document Type: Article

References (37)

1. Al-Hasani K, Vadolas J, Knaupp AS, Wardan H, Voullaire L, Williamson R, Ioannou PA. A 191-kb genomic fragment containing the human alpha-globin locus can rescue alpha-thalassemic mice. Mamm Genome 16: 847-853, 2005.
2. Antoch MP, Song EJ, Chang AM, Vitaterna MH, Zhao Y, Wilsbacher LD, Sangoram AM, King DP, Pinto LH, Takahashi JS. Functional identification of the mouse circadian Clock gene by transgenic BAC rescue. Cell 89: 655-667, 1997.
3. Brandt W, Khandekar M, Suzuki N, Yamamoto M, Lim KC, Engel JD. Defining the functional boundaries of the Gata2 locus by rescue with a linked bacterial artificial chromosome transgene. J Biol Chem 283: 8976-8983, 2008.
4. Chandler J, Hohenstein P, Swing DA, Tessarollo L, Sharan SK. Human BRCA1 gene rescues the embryonic lethality of Brca1 mutant mice. Genesis 29: 72-77, 2001.
5. Chen Y, Rao F, Rodriguez-Flores JL, Mahapatra NR, Mahata M, Wen G, Salem RM, Shih PA, Das M, Schork NJ, Ziegler MG, Hamilton BA, Mahata SK, O'Connor DT. Common genetic variants in the chromogranin A promoter alter autonomic activity and blood pressure. Kidney Int 74: 115-125, 2008.
6. Chen Y, Rao F, Rodriguez-Flores JL, Mahata M, Fung MM, Stridsberg M, Vaingankar SM, Wen G, Salem RM, Das M, Cockburn MG, Schork NJ, Ziegler MG, Hamilton BA, Mahata SK, Taupenot L, O'Connor DT. Naturally occurring human genetic variation in the 3′-untranslated region of the secretory protein chromogranin A is associated with autonomic blood pressure regulation and hypertension in a sex-dependent fashion. J Am Coll Cardiol 52: 1468-1481, 2008.
7. Corti A, Gasparri A, Chen FX, Pelagi M, Brandazza A, Sidoli A, Siccardi AG. Characterisation of circulating chromogranin A in human cancer patients. Br J Cancer 73: 924-932, 1996.
8. Coutinho JM, Singaraja RR, Kang M, Arenillas DJ, Bertram LN, Bissada N, Staels B, Fruchart JC, Fievet C, Joseph-George AM, Wasserman WW, Hayden MR. Complete functional rescue of the ABCA1-/- mouse by human BAC transgenesis. J Lipid Res 46: 1113-1123, 2005.
9. De Gasperi R, Friedrich VL, Perez GM, Senturk E, Wen PH, Kelley K, Elder GA, Gama Sosa MA.Transgenic rescue of Krabbe disease in the twitcher mouse. Gene Ther 11: 1188-1194, 2004.
10. Hashimoto K, Oreffo RO, Gibson MB, Goldring MB, Roach HI. DNA demethylation at specific CpG sites in the IL1B promoter in response to inflammatory cytokines in human articular chondrocytes. Arthritis Rheum 60: 3303-3313, 2009.
11. Healy E, Jordan SA, Budd PS, Suffolk R, Rees JL, Jackson IJ. Functional variation of MC1R alleles from red-haired individuals. Hum Mol Genet 10: 2397-2402, 2001.
12. Helle KB, Corti A, Metz-Boutigue MH, Tota B. The endocrine role for chromogranin A: a prohormone for peptides with regulatory properties. Cell Mol Life Sci 64: 2863-2886, 2007.
13. Horike SI, Ferreira JC, Meguro-Horike M, Choufani S, Smith AC, Shuman C, Meschino W, Chitayat D, Zackai E, Scherer SW, Weksberg R. Screening of DNA methylation at the H19 promoter or the distal region of its ICR1 ensures efficient detection of chromosome 11p15 epimutations in Russell-Silver syndrome. Am J Med Genet A 149A: 2415-2423, 2009.
14. Kennedy BP, Mahata SK, O'Connor DT, Ziegler MG. Mechanism of cardiovascular actions of the chromogranin A fragment catestatin in vivo. Peptides 19: 1241-1248, 1998.
15. Kibar Z, Gauthier S, Lee SH, Vidal S, Gros P. Rescue of the neural tube defect of loop-tail mice by a BAC clone containing the Ltap gene. Genomics 82: 397-400, 2003.
16. Kruger PG, Mahata SK, Helle KB. Catestatin (CgA344-364) stimulates rat mast cell release of histamine in a manner comparable to mastoparan and other cationic charged neuropeptides. Regul Pept 114: 29-35, 2003.
17. Laslop A, Mahata SK. Neuropeptides and chromogranins: session overview. Ann NY Acad Sci 971: 294-299, 2002.
18. Mahapatra NR, O'Connor DT, Vaingankar SM, Hikim AP, Mahata M, Ray S, Staite E, Wu H, Gu Y, Dalton N, Kennedy BP, Ziegler MG, Ross J, Mahata SK. Hypertension from targeted ablation of chromogranin A can be rescued by the human ortholog. J Clin Invest 115: 1942-1952, 2005.
19. Mahata SK, Mahapatra NR, Mahata M, Wang TC, Kennedy BP, Ziegler MG, O'Connor DT. Catecholamine secretory vesicle stimulus-transcription coupling in vivo. Demonstration by a novel transgenic promoter/photoprotein reporter and inhibition of secretion and transcription by the chromogranin A fragment catestatin. J Biol Chem 278: 32058-32067, 2003.
20. Mahata SK, Mahata M, Wakade AR, O'Connor DT. Primary structure and function of the catecholamine release inhibitory peptide catestatin [chromogranin A(344-364)]: identification of amino acid residues crucial for activity. Mol Endocrinol 14: 1525-1535, 2000.
21. Mahata SK, O'Connor DT, Mahata M, Yoo SH, Taupenot L, Wu H, Gill BM, Parmer RJ. Novel autocrine feedback control of catecholamine release. A discrete chromogranin a fragment is a noncompetitive nicotinic cholinergic antagonist. J Clin Invest 100: 1623-1633, 1997.
22. Means GD, Boyd Y, Willis CR, Derry JM. Transgenic rescue of the tattered phenotype by using a BAC encoding Ebp. Mamm Genome 12: 323-325, 2001.
23. Montero-Hadjadje M, Vaingankar S, Elias S, Tostivint H, Mahata SK, Anouar Y. Chromogranins A and B and secretogranin II: evolutionary and functional aspects. Acta Physiol (Oxf) 192: 309-324, 2008.
24. O'Connor DT. Chromogranin A: implications for hypertension. J Hypertens Suppl 2: S147-S150, 1984.
25. O'Connor DT, Kailasam MT, Kennedy BP, Ziegler MG, Yanaihara N, Parmer RJ. Early decline in the catecholamine release-inhibitory peptide catestatin in humans at genetic risk of hypertension. J Hypertens 20: 1335-1345, 2002.
26. Pedram M, Sprung CN, Gao Q, Lo AW, Reynolds GE, Murnane JP. Telomere position effect and silencing of transgenes near telomeres in the mouse. Mol Cell Biol 26: 1865-1878, 2006.
27. Rao F, Wen G, Gayen JR, Das M, Vaingankar SM, Rana BK, Mahata M, Kennedy BP, Salem RM, Stridsberg M, Abel K, Smith DW, Eskin E, Schork NJ, Hamilton BA, Ziegler MG, Mahata SK, O'Connor DT. Catecholamine release-inhibitory peptide catestatin [chromogranin A(352-372)]: naturally occurring amino acid variant Gly364Ser causes profound changes in human autonomic activity and alters risk for hypertension. Circulation 115: 2271-2281, 2007.
28. Ratti S, Curnis F, Longhi R, Colombo B, Gasparri A, Magni F, Manera E, Metz-Boutigue MH, Corti A. Structure-activity relationships of chromogranin A in cell adhesion. Identification of an adhesion site for fibroblasts and smooth muscle cells. J Biol Chem 275: 29257-29263, 2000.
29. Sharan SK, Pyle A, Coppola V, Babus J, Swaminathan S, Benedict J, Swing D, Martin BK, Tessarollo L, Evans JP, Flaws JA, Handel MA. BRCA2 deficiency in mice leads to meiotic impairment and infertility. Development 131: 131-142, 2004.
30. Siegal ML, Hartl DL. An experimental test for lineage-specific position effects on alcohol dehydrogenase (Adh) genes in Drosophila. Proc Natl Acad Sci USA 95: 15513-15518, 1998.
31. Singh J, Freeling M, Lisch D. A position effect on the heritability of epigenetic silencing. PLoS Genet 4: e1000216, 2008.
32. Takiyyuddin MA, Cervenka JH, Hsiao RJ, Barbosa JA, Parmer RJ, O'Connor DT. Chromogranin A. Storage and release in hypertension. Hypertension 15: 237-246, 1990.
33. Takiyyuddin MA, Parmer RJ, Kailasam MT, Cervenka JH, Kennedy B, Ziegler MG, Lin MC, Li J, Grim CE, Wright FA, O'Connor DT. Chromogranin A in human hypertension. Influence of heredity. Hypertension 26: 213-220, 1995.
34. Tanimoto K, Sugiura A, Kanafusa S, Saito T, Masui N, Yanai K, Fukamizu A. A single nucleotide mutation in the mouse renin promoter disrupts blood pressure regulation. J Clin Invest 118: 1006-1016, 2008.
35. Taupenot L, Harper KL, O'Connor DT. The chromogranin-secretogranin family. N Engl J Med 348: 1134-1149, 2003.
36. Weiler KS, Wakimoto BT. Heterochromatin and gene expression in Drosophila. Annu Rev Genet 29: 577-605, 1995.
37. Winkler H, Fischer-Colbrie R. The chromogranins A and B: the first 25 years and future perspectives. Neuroscience 49: 497-528, 1992.